<i>In vivo</i> PK evaluation of WT BMP9 in naïve SD rats. by Tobias G. Schips (21799838)

Subjects:

Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i> by Tobias G. Schips (21799838)

Subjects:

Characterization of safety pharmacology of WT BMP9 in rats. by Tobias G. Schips (21799838)

Subjects:

The process of the proposed glaucoma classification method. by Sirikorn Sangchocanonta (20917797)

Subjects:

Group control-after intervention. by Nan Tang (642590)

Subjects:

Flowchart of literature screening process. by Shangtian Wang (20933822)

Subjects:

Seasonal Influenza activity from 2020-2023 in Southeast Asia and Southern Asia. by Nadia Nisar (311028)

Subjects:

The details of literature inclusion and exclusion. by Shangtian Wang (20933822)

Subjects:

Samples Tested and Positive Samples During Pre- and Post-Pandemic Periods. by Nadia Nisar (311028)

Subjects:

Map with color coding showing the relative risk of loss at the regional level for each country in Sub-Saharan Africa. by Beatrice T. Nganso (4114768)

Subjects:

Group SFA-before intervention. by Nan Tang (642590)

Subjects:

Pie charts showing the different patterns of risk factors associated with total colony losses. by Beatrice T. Nganso (4114768)

Subjects:

Pie charts showing the different patterns of risk factors associated with total colony losses by regions within Kenya by Beatrice T. Nganso (4114768)

Subjects:

Seasonal Influenza activity from 2017-2023 in SEAR and WPR region. by Nadia Nisar (311028)

Subjects:

Comparison of ten Asian countries with pre and post pandemic influenza activity sources through Flunet. by Nadia Nisar (311028)

Subjects:

Lost cases. by Nan Tang (642590)

Subjects:

Basic characteristics of included literature. by Shangtian Wang (20933822)

Subjects:

Baseline sociodemographic data and disease-related variables of two groups (n = 105). by Nan Tang (642590)

Subjects:

Analysis of SAS, SDS, PSQI, and FertiQoL scores. by Nan Tang (642590)

Subjects:

Boxplot rate of influenza positivity value by period. by Nadia Nisar (311028)

Subjects: